MORGAN STANLEY - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 26 filers reported holding BRIACELL THERAPEUTICS CORP in Q1 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q2 2023$482,964
-8.4%
75,228
+6.3%
0.00%
Q1 2023$526,990
+2973.4%
70,737
+1702.7%
0.00%
Q4 2022$17,147
+0.9%
3,924
+31.8%
0.00%
Q3 2022$17,000
+6.2%
2,977
+4.5%
0.00%
Q2 2022$16,000
-92.2%
2,850
-85.9%
0.00%
Q1 2022$206,000
+202.9%
20,258
+144.2%
0.00%
Q4 2021$68,000
+15.3%
8,297
+14.3%
0.00%
Q3 2021$59,000
-39.2%
7,261
-60.2%
0.00%
Q2 2021$97,00018,2270.00%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 750,000$7,605,0008.16%
K.J. Harrison & Partners Inc 1,351,782$13,749,0002.21%
Redmond Asset Management, LLC 137,942$1,399,0000.42%
SABBY MANAGEMENT, LLC 29,962$304,0000.04%
Concord Wealth Partners 16,775$170,0000.04%
Leonard Green & Partners, L.P. 500,000$5,070,0000.04%
Summit Trail Advisors, LLC 35,000$355,0000.03%
WASATCH ADVISORS LP 244,691$2,481,0000.01%
Apollon Wealth Management, LLC 13,900$141,0000.01%
NATIONAL BANK OF CANADA /FI/ 156,900$1,591,0000.01%
View complete list of BRIACELL THERAPEUTICS CORP shareholders